−515KRW
−21.95 BKRW
12.70 BKRW
44.59 M
About KANGSTEM BIOTECH
Sector
Industry
CEO
Jong-Cheon Na
Website
Headquarters
Seoul
Employees (FY)
113
Founded
2010
ISIN
KR7217730001
FIGI
BBG00BDZ1NT0
KANGSTEM BIOTECH Co., Ltd. engages in the manufacture, development, and sale of stem cell therapy products. Its services include next generation and gene-loaded stem cell. The company was founded by Kyung-Sun Kang on October 29, 2010 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 217730 is 2 375 KRW — it has increased by 1.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KANGSTEM BIOTECH stocks are traded under the ticker 217730.
Yes, you can track KANGSTEM BIOTECH financials in yearly and quarterly reports right on TradingView.
Like other stocks, 217730 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANGSTEM BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 113.00 employees. See our rating of the largest employees — is KANGSTEM BIOTECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANGSTEM BIOTECH EBITDA is −18.52 B KRW, and current EBITDA margin is −152.63%. See more stats in KANGSTEM BIOTECH financial statements.